Drawing for AVACC 10

USPTO serial 79346219

AVACC 10

Reviewed by CopyMark Law Group

Reg. 7226960Status 700Registered
Filing date
Status date
Registration date
Nov 28, 2023
Examiner
MARTIN, LIEF ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AVACC 10?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Greger

Jeffrey H. Greger STUDEBAKER BRACKETT PLLC8255 Greensboro DriveSuite 300Tysons, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and preparations for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases and allergic diseases, as well as pharmaceutical products and preparations against cancer; vaccines; and medicines for human use for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases, allergic diseases and cancer; bacterial and viral vaccines, synthetic, recombinant, peptide, protein, RNA-, DNA- and therapeutic vaccines; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugatesACTIVE—
010Apparatus and containers for the administration of vaccines and medicines, namely cups for dispensing medicine, injection needles for the administration of vaccines and medicines, injection instruments without needles for the administration of vaccines and medicines, nose sprayers for medical purposes and spray syringes for medical purposes; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugatesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 26, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 29, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 29, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 28, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 28, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 28, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 12, 2023GPNXNOTIFICATION PROCESSED BY IB—
Sep 12, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 12, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 23, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 23, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 23, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 4, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2023RFNTREFUSAL PROCESSED BY IB—
Apr 26, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 26, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 8, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2023DOCKASSIGNED TO EXAMINER—
Aug 2, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance